Synthesis, crystal structure, and solubility study of a supramolecular assembly cocrystal formed by levofloxacin and nicotinic acid

M Li, Z Yang, Y Zhang, H Xu, S Zhang, J Sun… - Journal of Molecular …, 2022 - Elsevier
A novel chemical structure named pharmaceutical cocrystal was synthesized with the
purpose to enhance the solubility of levofloxacin (LVFX). Nicotinic acid (NA) was selected as …

Preparation of itraconazole nanoparticles by anti-solvent precipitation method using a cascaded microfluidic device and an ultrasonic spray drier

X Zhang, H Chen, F Qian, Y Cheng - Chemical Engineering Journal, 2018 - Elsevier
We propose a cascaded device connecting microfluidic nanoprecipitation and ultrasonic
spray drying to produce dry drug nanoparticles directly. Itraconazole (ITZ) was chosen as a …

Exploring the Solid-State Landscape of Atropisomers in (±)-Lesinurad: Insights into Crystallographic Analysis, Transformation Behavior, and Dissolution Performance

X Zhou, J Ye, Z Jin, Y Kang, X Hu - Crystal Growth & Design, 2024 - ACS Publications
Axial chirality is a unique form of chirality characterized by restricted rotation around a
covalent bond due to steric or electronic hindrances, a phenomenon known as …

Three new orbifloxacin multicomponent crystal forms towards pharmaceutical improvement

OMM Santos, JTJ Freitas, M Bitencourt… - Journal of Molecular …, 2020 - Elsevier
Orbifloxacin (ORBI) is a third-generation synthetic fluoroquinolone used as an antimicrobial
veterinary drug for the treatment of gastrointestinal and respiratory infections. Structural …

[PDF][PDF] Fabrication and solid state characterization of ticagrelor co-crystals with improved solubility and dissolution

G Pai, MB Sathyanarayana - BDL, 2017 - researchgate.net
In the present study a new co-crystal of Ticagrelor with L-Tartaric acid has been prepared
with improved solubility. Ticagrelor is a class VI drug with poor solubility and permeability; …

Energy framework and solubility: a new predictive model in the evaluation of the structure–property relationship of pharmaceutical solid forms

JTJ Freitas, LF Diniz, DS Gomes, PMAF de Paula… - …, 2022 - pubs.rsc.org
The active pharmaceutical ingredient (API) is a drug product's biologically active chemical
substance that produces the desired therapeutic effects. Most APIs are small organic …

[PDF][PDF] Use of glutaric acid to improve the solubility and dissolution profile of glipizide through pharmaceutical cocrystallization

F Batool, M Ahmad, MU Minhas, Q Khalid… - Acta Poloniae …, 2019 - bibliotekanauki.pl
The purpose of current study was to improve the solubility and dissolution profile of BCS
class-II drug Glipizide using glutaric acid as a coformer via various cocrystalization …

[PDF][PDF] Evaluation of Physicochemical Parameters of Piroxicam 20 mg Tablets Commercially Available in District Larkana, Sindh

A Dayo, MI Arain, A Ahmer, R Irfan, B Shaikh, M Qazi… - academia.edu
The objective of this study is to evaluate the physicochemical parameters of Piroxicam 20
mg Tablet brands. A comparative qualitative research study was conducted for a period of …

Estudo estrutural e físico-químico de formas sólidas da buclizina

MB SILVA - 2019 - bdtd.unifal-mg.edu.br
RESUMO A busca por Ingredientes Farmaceuticamente Ativos (IFA), de maior solubilidade,
tem motivado vários estudos envolvendo Engenharia de Cristais de moléculas de fármacos …

[引用][C] 原料药粒径对头孢地尼颗粒体外溶出行为的影响

刘为中, 李志云, 查晓雁 - 安徽医药, 2015